Physician

Phillip R Hynes, MD

According to 2025 Medicare claims, Phillip Hynes, MD (NPI: 1508881244) practices radiation oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is NEBRASKA HEMATOLOGY-ONCOLOGY, PC (NPI: 1205915071; TIN: 911806105) and primary practice location at 68516-6537. Hynes is affiliated with the Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Hynes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 274 traditional Medicare patients, billed 6,976 HCPCS/CPT codes, and received $1,198,340 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 130 prescription claims across 75 beneficiaries totaling $3,275 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 5 records totaling $269. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,769 and ending at $3,275. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.1M2015 Medicare payment: $1,015,296 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $961,134 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,185,457 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,515,699 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,483,011 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,096,116 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,337,457 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,190,516 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,088,294 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,198,340 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152186,532$1,015,296
20162376,228$961,134
20172987,813$1,185,457
201825910,554$1,515,699
20193109,892$1,483,011
202026814,390$2,096,116
20212838,307$1,337,457
20222967,847$1,190,516
20232996,251$1,088,294
20242746,976$1,198,340

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.2K$10K2015 Drug cost: $5,769 (USD; Tot_Drug_Cst)2016 Drug cost: $4,505 (USD; Tot_Drug_Cst)2017 Drug cost: $10,383 (USD; Tot_Drug_Cst)2018 Drug cost: $7,879 (USD; Tot_Drug_Cst)2019 Drug cost: $5,078 (USD; Tot_Drug_Cst)2020 Drug cost: $5,141 (USD; Tot_Drug_Cst)2021 Drug cost: $5,547 (USD; Tot_Drug_Cst)2022 Drug cost: $4,709 (USD; Tot_Drug_Cst)2023 Drug cost: $3,156 (USD; Tot_Drug_Cst)2024 Drug cost: $3,275 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201527105$5,769
20163595$4,505
201745162$10,383
201852177$7,879
201956207$5,078
202062212$5,141
202172183$5,547
202271188$4,709
202355133$3,156
202475130$3,275

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more128128$157
77263Complex radiation therapy planning138145$121
77334Design and construction of complex radiation treatment device125230$92
77336Continuing radiation therapy consultation per week124463$63
77300Calculation of radiation therapy dose125531$48

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl1027,682$2,328

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$269Elekta, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Phillip R. Hynes, MD?

Tedicare shows public-source Medicare data for Phillip R. Hynes, MD (NPI 1508881244), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Phillip R. Hynes, MD have ACO affiliation data?

Phillip R. Hynes, MD is shown with ACO affiliation data for Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Phillip R. Hynes, MD?

Phillip R. Hynes, MD is linked to NEBRASKA HEMATOLOGY-ONCOLOGY, PC (billing NPI 1205915071) in the available physician profile data.

Does Phillip R. Hynes, MD have Open Payments data?

Phillip R. Hynes, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.